-+ 0.00%
-+ 0.00%
-+ 0.00%
Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58
Share
Listen to the news
Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58
  • Telix Pharmaceuticals: Group Chief Financial Officer Darren Charlton Smith increased his stake via a purchase of 2,071 ordinary shares.
  • Deal price was AUD 9.66 per share.
  • Directly held ordinary shares rose to 13,992.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-061944), on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending